Oracle shares soared to record highs after reporting strong Q4 results and raising fiscal 2026 revenue guidance, driven by explosive growth in AI cloud services and enterprise demand.

BioNTech's $1.25 billion acquisition of CureVac creates a "German biotech champion" focused on mRNA-based cancer treatments, with CureVac shares surging 38% on the announcement.

America's Car-Mart reported a substantial increase in earnings per share for the fourth quarter, exceeding market ...